CLINICAL CHARACTERISTICS AND TREATMENT RESULTS OF PEDIATRIC RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMAS
Author:
Publisher
Publishing House ABV Press
Subject
Oncology,Hematology
Reference50 articles.
1. Valiev T.T., Popa A.V., Levashov A.S. et al. Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience. Klinicheskaya onkogematologiya = Clinical oncohematology 2016;9(4): 420–37 (In Russ.). DOI: 10.21320/2500-2139-2016-9-4-420-437.
2. Kobrinsky N.L., Sposto R., Shah N.R. et al. Outcomes of treatment of children and adolescents with recurrent nonHodgkin’s lymphoma and Hodgkin’s disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children’s Cancer Group Study CCG-5912. J Clin Oncol 2001;19(9):2390–6. DOI: 10.1200/JCO.2001.19.9.2390. PMID: 11331317
3. Seidemann K., Tiemann M., Schrappe M. et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 2001;97(12):3699–3706. PMID: 11389005.
4. Woessmann W., Zimmermann M., Lenhard M. et al. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-FrankfurtMuenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol 2011;29(22):3065–71. DOI: 10.1200/JCO.2011.34.8417. PMID: 21709186.
5. Brugieres L., Pacquement H., Le Deley M.C. et al. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol 2009;27(30):5056–61. DOI: 10.1200/JCO.2008.20.1764. PMID: 19738127.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Features of relapses and refractory forms of T-lymphoblastic lymphoma in children;Pediatric Hematology/Oncology and Immunopathology;2020-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3